Tosk, Inc.   Report issue

For profit Phase 2
Founded: Mountain View CA United States (1998)

Organization Overview

First Clinical Trial
2019
NCT04046250
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Tosk, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

tk-112690 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mucositis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1